Global Cardiac Cannula Market Size, Share, Trends & Growth Analysis Report Segmented By Product Type (Venous Cannulas, Arterial Cannulas, Specialized Cannulas, Multi-purpose Cannulas), Design Type, Application, Material, End User And Regions (North America, Europe, Asia-Pacific, Latin America, Middle East and Africa), 2025-2034

The global Cardiac Cannula market is forecasted to grow at a noteworthy CAGR of 7.49% between 2025 and 2033. By 2033, market size is expected to surge to USD 5.63 Billion, a substantial rise from the USD 2.94 Billion recorded in 2024.

Cardiac Cannula Market Size and Forecast 2025 to 2033

The Cardiac Cannula market is poised for significant expansion, propelled by the increasing global incidence of cardiovascular diseases, which necessitates a rising number of cardiac surgical interventions. The continuous advancements in cardiac surgical techniques, particularly the growing adoption of minimally invasive procedures and extracorporeal membrane oxygenation (ECMO), are major drivers for market growth. Furthermore, the aging global population, inherently more susceptible to cardiac ailments, contributes substantially to the demand for these critical medical devices. Opportunities within this market are also emerging from technological innovations focused on enhancing cannula biocompatibility, flexibility, and safety, as well as the expanding healthcare infrastructure in developing economies. These combined factors underscore a robust growth trajectory for the cardiac cannula market through 2033.

Market Dynamics

Cardiac Cannula Market Drivers

• Rising Global Prevalence of Cardiovascular Diseases: The escalating global burden of cardiovascular diseases (CVDs) is a primary driver for the Cardiac Cannula market. CVDs remain the leading cause of death globally, taking an estimated 17.9 million lives each year, according to the World Health Organization. This high and increasing incidence of heart conditions, including coronary artery disease, valvular heart disease, and congenital heart defects, directly translates into a greater need for diagnostic and therapeutic cardiac procedures. These interventions, such as coronary artery bypass grafting (CABG) and valve repair/replacement, invariably require the use of cardiac cannulas to facilitate extracorporeal circulation or direct access to the heart, thus sustaining strong market demand.
• Growing Number of Cardiac Surgical Procedures: The increasing volume of cardiac surgical procedures performed worldwide is a significant driver for the cardiac cannula market. Advances in surgical techniques, improved patient outcomes, and expanding access to specialized cardiac care contribute to this growth. For instance, high-income countries perform an average of 123.2 cardiac surgical procedures per 100,000 population annually, as per a research study on global cardiac surgical volume. These procedures, ranging from complex open-heart surgeries to minimally invasive interventions, are critically dependent on cardiac cannulas for blood diversion, perfusion, and targeted delivery of solutions. The continuous increase in surgical caseloads directly translates to higher consumption of cannulas.
• Advancements in Extracorporeal Membrane Oxygenation (ECMO) Use: The expanding application and technological advancements in Extracorporeal Membrane Oxygenation (ECMO) therapy are significantly driving the cardiac cannula market. ECMO provides temporary cardiac and/or respiratory support for patients with life-threatening heart or lung failure, and its adoption has increased across various critical care settings. The global ECMO machine market is projected to reach significant growth, with increasing survival rates with ECMO therapy noted as a key opportunity, according to a market analysis. This growing reliance on ECMO, particularly for conditions like acute respiratory distress syndrome (ARDS) and as a bridge to transplant, necessitates a steady supply of specialized cardiac cannulas for safe and effective vascular access and blood circulation outside the body.
• Increasing Incidence of Congenital Heart Defects: The persistent incidence of congenital heart defects (CHDs) globally serves as a crucial driver for the cardiac cannula market. CHDs are among the most common birth defects, affecting approximately 1% of live births worldwide, as indicated by a study on the global epidemiology of congenital heart disease. Many of these defects necessitate complex surgical repair in infants and children, procedures that fundamentally rely on cardiac cannulas for cardiopulmonary bypass. Despite advancements, CHD remains a leading cause of mortality among infants, underscoring the ongoing need for surgical interventions. This consistent patient population ensures a foundational and continuous demand for cannulas specifically designed for pediatric cardiac applications.

Cardiac Cannula Market Opportunities

• Growing Adoption of Minimally Invasive Cardiac Procedures: The increasing global adoption of minimally invasive cardiac surgical procedures presents a significant opportunity for innovation and market expansion in cardiac cannulas. These procedures, such as Transcatheter Aortic Valve Replacement (TAVR) and minimally invasive valve repairs, require specialized cannulas that are smaller, more flexible, and designed for precise percutaneous or small-incision access. TAVR procedures, for instance, have been performed in hundreds of thousands of patients globally with adoption increasing rapidly, highlighting the shift towards less invasive techniques. This trend drives demand for cannulas optimized for reduced invasiveness, improved patient outcomes, and faster recovery times, creating a fertile ground for manufacturers to develop advanced, purpose-built products.
• Development of Advanced Biocompatible Materials: The ongoing development and adoption of advanced biocompatible materials present a significant opportunity for enhancing cardiac cannula performance and market value. Materials that minimize thrombogenicity, inflammation, and immune response are highly sought after to improve patient safety and reduce complications during extracorporeal circulation. For instance, ISO 10993-1 provides guidelines for the biological evaluation of medical devices, emphasizing the importance of biocompatibility. Innovations in polymer science and surface coatings that improve blood compatibility can lead to cannulas with longer indwelling times and reduced risk of adverse events, opening avenues for premium products and increased clinician confidence in these crucial devices.
• Expansion of Healthcare Infrastructure in Emerging Economies: The rapid expansion and modernization of healthcare infrastructure in emerging economies offer substantial growth opportunities for the cardiac cannula market. Governments and private entities in regions like Asia-Pacific and Latin America are increasing investments in establishing new hospitals, cardiac care units, and specialized surgical centers to cater to their large and growing populations. The Asia-Pacific healthcare market is projected to experience significant growth, driven by demographic shifts and increased investment. This development inherently leads to a higher volume of cardiac surgeries and interventional procedures, thereby increasing the demand for essential components like cardiac cannulas. Manufacturers focusing on these regions can tap into a burgeoning market with unmet needs.
• Increasing Demand for Disposable and Single-Use Cannulas: The escalating global emphasis on infection control and patient safety within healthcare settings is driving a substantial opportunity for disposable and single-use cardiac cannulas. The use of single-use devices significantly mitigates the risk of healthcare-associated infections (HAIs), which are a major concern in hospitals worldwide. For instance, a survey found that one in five patients are diagnosed with a device-associated HAI, leading to significant financial burden. While not specifically on cannulas, the broader medical disposables market is experiencing significant growth due to factors like HAIs. This trend encourages manufacturers to innovate in design and materials for cost-effective, high-quality disposable cannulas, ensuring optimal sterility and reducing the burden of reprocessing.

Cardiac Cannula Market Restrain & Challenges

• Stringent Regulatory Approvals and Compliance: The Cardiac Cannula market faces significant restraint due to the highly stringent and evolving regulatory landscape governing medical devices. Manufacturers must navigate complex approval processes mandated by bodies such as the U.S. Food and Drug Administration (FDA) and the European Medical Device Regulation (MDR). These regulations demand extensive clinical trials, rigorous testing for biocompatibility, sterility, and performance, along with comprehensive documentation. The complexity and lengthy nature of these approvals can significantly increase development costs and time-to-market, posing a considerable challenge for manufacturers, particularly for innovative designs or new materials.
• High Cost of Cardiac Procedures and Devices: The inherently high cost associated with cardiac surgical procedures and the specialized medical devices, including cardiac cannulas, presents a significant market restraint. These costs encompass not only the devices themselves but also highly skilled personnel, advanced hospital infrastructure, and post-operative care. In many regions, healthcare systems and individual patients face considerable financial burdens, which can limit access to necessary procedures. The high expenses can constrain adoption, especially in developing countries or healthcare systems with limited budgets, thus impacting the overall market growth for premium or advanced cannula products.
• Risk of Complications Associated with Cannulation: The inherent risks and potential complications associated with the cannulation process itself pose a significant challenge for the cardiac cannula market. Complications such as vascular injury, bleeding, infection, thrombus formation, and cannula malpositioning can lead to severe adverse patient outcomes and extend hospital stays. Healthcare-associated infections, for instance, affect millions of patients in Europe annually, as reported by the European Centre for Disease Prevention and Control, highlighting the pervasive risk. While continuous design improvements aim to minimize these risks, the very nature of invasive procedures means that complications remain a concern, influencing clinician choice and patient acceptance of cardiac interventions.
• Supply Chain Disruptions and Raw Material Volatility: The Cardiac Cannula market is susceptible to significant challenges arising from global supply chain disruptions and volatility in raw material prices. The production of cannulas relies on specialized medical-grade polymers, metals, and coatings, whose availability and cost can be impacted by geopolitical events, trade policies, and global demand fluctuations. The medical device industry, like many others, has experienced vulnerabilities in its supply chain, particularly during global crises. Such disruptions can lead to manufacturing delays, increased production costs, and potential shortages of critical components, ultimately affecting market stability and the timely delivery of essential cardiac cannulas to healthcare providers.

Current Trends in the Cardiac Cannula Market

• Growing Adoption of Minimally Invasive Access Cannulas: A significant trend in the Cardiac Cannula market is the increasing adoption of cannulas specifically designed for minimally invasive cardiac procedures. This shift is driven by the desire for reduced patient trauma, faster recovery times, and improved cosmetic outcomes. These cannulas are often smaller in diameter, more flexible, and incorporate features for precise placement through small incisions or percutaneously. Advances in minimally invasive cardiac surgery, including enhanced visualization tools, are improving patient outcomes, as highlighted by recent medical reports. This trend is pushing manufacturers to innovate in design, materials, and deployment mechanisms for cannulas that facilitate these less-invasive approaches, thereby catering to a growing procedural preference.
• Development of Biocompatible and Anti-Thrombogenic Coatings: A prominent trend in the cardiac cannula market involves the development and application of advanced biocompatible and anti-thrombogenic coatings on cannula surfaces. These coatings are designed to reduce the risk of blood clot formation and inflammatory responses, thereby improving patient safety and extending the duration of safe use during extracorporeal circulation. The biological evaluation of medical devices, including assessments for hemocompatibility, is governed by standards like ISO 10993-4. Manufacturers are investing in research to create novel surface modifications that actively repel platelets and proteins, aiming to minimize complications such as thrombosis and reduce the need for high doses of anticoagulants, ultimately leading to better patient outcomes.
• Integration of Imaging and Sensor Technologies into Cannulas: The market is witnessing an emerging trend towards integrating advanced imaging and sensor technologies directly into cardiac cannulas. This innovation aims to provide real-time feedback during cannulation, improving placement accuracy and minimizing complications. For instance, cannulas might incorporate ultrasound transducers for precise visualization of vessel anatomy or pressure sensors to monitor blood flow dynamics. While specific government statistics on "smart cannulas" are limited, the broader trend in medical devices towards enhanced precision and real-time monitoring is well-documented within healthcare technology. This integration offers the potential for significantly safer and more efficient cannulation procedures, reducing the risks associated with blind insertion and improving overall surgical outcomes.
• Shift Towards Single-Use and Disposable Cannulas: The cardiac cannula market is experiencing a notable shift towards the increased utilization of single-use and disposable cannulas. This trend is primarily driven by heightened concerns regarding hospital-acquired infections (HAIs) and the associated costs and patient morbidity. Using disposable cannulas eliminates the need for reprocessing, thereby mitigating the risk of cross-contamination and ensuring sterility for each patient. The global medical disposables market is projected to reach significant size due to factors such as rising HAIs and increasing surgical procedures. This strategic pivot by manufacturers aims to address infection control imperatives, streamline hospital workflows by removing sterilization burdens, and enhance overall patient safety within cardiac surgical settings.

Segmentation Insights

Cardiac Cannula market Analysis, By Product Type

By product types, the market is categorized into  Venous Cannulas, Arterial Cannulas, Specialized Cannulas, and Multi-purpose Cannulas,.

• Venous Cannulas represent the largest segment. This dominance is primarily due to their critical and extensive use in nearly all cardiac surgical procedures requiring cardiopulmonary bypass. Venous cannulas are essential for draining deoxygenated blood from the patient to the heart-lung machine, a fundamental step in open-heart surgery. Their larger size and diverse configurations needed to accommodate varying patient anatomies and flow rates also contribute to their high volume of production and use. The sheer number of cardiac surgeries performed globally ensures a consistent and leading demand for venous cannulas.
• The fastest-growing segment within the product type category is Specialized Cannulas. This rapid growth is driven by the increasing complexity of cardiac interventions and the rising adoption of advanced techniques such as Transcatheter Aortic Valve Replacement (TAVR), Extracorporeal Membrane Oxygenation (ECMO) for specific indications, and minimally invasive cardiac surgery. These specialized procedures often require cannulas with unique designs, smaller diameters, enhanced flexibility, or specific tip configurations for precise access and controlled flow in challenging anatomical locations. The ongoing innovation in interventional cardiology and cardiac assist devices, leading to more tailored procedural requirements, fuels the accelerated demand for these highly specialized and often premium-priced cannulas.

Cardiac Cannula market Analysis, By Design Type

By Design Type, the market is categorized into Single-lumen Cannulas, Multi-lumen Cannulas, Guide Cannulas, and Bio-compatible Cannulas.

• Among these design types, Single-lumen Cannulas constitute the largest segment. This leading position is primarily due to their fundamental role in a wide array of cardiac procedures where a single pathway for blood flow or fluid delivery is sufficient. Their simpler design makes them more cost-effective to manufacture and widely applicable across various standard cardiac surgical interventions. Single-lumen cannulas are the workhorse in many traditional cardiopulmonary bypass setups for both venous drainage and arterial return. Their versatility and broad utility across different patient populations and surgical approaches ensure their sustained high demand and dominant market share.
• The fastest-growing segment within the design type category is Bio-compatible Cannulas. This rapid expansion is driven by the increasing emphasis on improving patient safety, reducing complications such as thrombogenicity and inflammation, and enhancing outcomes during prolonged extracorporeal support. Bio-compatible cannulas are coated or manufactured with materials designed to minimize adverse interactions with blood components and the vascular system, leading to better clinical results and reduced systemic inflammatory response. While not directly quantifiable by a government agency, the growing body of research and clinical evidence supporting the benefits of enhanced biocompatibility, particularly for applications like ECMO and long-duration bypass, is accelerating their adoption, despite potentially higher manufacturing costs.

Cardiac Cannula market Analysis, By Application

By Application, the market is categorized into Cardiac Surgery, Cardiac Assist Devices, Extracorporeal Membrane Oxygenation (ECMO), and Transcatheter Aortic Valve Replacement (TAVR).

• Among these applications, Cardiac Surgery holds the largest share of the Cardiac Cannula market. This dominance is attributed to the vast number and variety of traditional open-heart surgical procedures performed globally, including coronary artery bypass grafting (CABG), valve repair and replacement, and congenital heart defect corrections. These surgeries fundamentally rely on cardiopulmonary bypass, which necessitates multiple cannulas for venous drainage, arterial return, and cardioplegia delivery. The sheer volume of these established surgical interventions, coupled with the ongoing need for conventional and specialized cannulas, ensures that cardiac surgery remains the primary and largest application segment for cardiac cannulas.
• The fastest-growing segment within the application category is Transcatheter Aortic Valve Replacement (TAVR). This rapid growth is propelled by the increasing prevalence of aortic stenosis, particularly in an aging population, and the procedural advantages of TAVR as a minimally invasive alternative to traditional open-heart surgery for many patients. TAVR procedures, which involve delivering a new heart valve via a catheter, require highly specialized and often smaller-diameter cannulas for vascular access and precise catheter guidance. The continuous expansion of TAVR indications to lower-risk patients and the global adoption of this innovative procedure are significantly driving the accelerated demand for cannulas specifically designed for transcatheter interventions.

Cardiac Cannula market Analysis, By Material

By Material, the market is categorized into Silicone, Polyurethane, Polyvinyl Chloride (PVC), and Metal-coated Cannulas.

• Among these materials, Polyurethane cannulas represent the largest segment. This dominance is primarily due to polyurethane's excellent combination of properties, including flexibility, kink resistance, and good biocompatibility, making it highly suitable for various cardiac applications. Polyurethane cannulas can be manufactured with thin walls to maximize lumen size while maintaining strength, facilitating optimal blood flow and minimizing trauma. Its versatility allows for a wide range of designs and applications in both venous and arterial cannulation, offering a favorable balance of performance and manufacturing cost. The material's adaptability to various sterilization methods further solidifies its leading position in the market.
• The fastest-growing segment within the material category is Silicone. This rapid growth is driven by silicone's superior biocompatibility, exceptional flexibility, and softness, which minimizes trauma to delicate vascular tissues and reduces the risk of long-term complications. Silicone cannulas are particularly favored in pediatric cardiac surgery and for prolonged extracorporeal support applications like ECMO, where minimizing inflammation and ensuring gentle tissue interaction are paramount. While typically more expensive than other materials, the increasing emphasis on patient safety, reduced complications, and improved outcomes, particularly for vulnerable patient populations, is accelerating the adoption of silicone-based cannulas, despite the higher production costs.

Cardiac Cannula market Analysis, By End User

By End User, the market is categorized into Hospitals, Ambulatory Surgical Centers, Cardiac Care Units, and Specialized Cardiac Clinics.

• Among these end-user segments, Hospitals constitute the largest portion of the Cardiac Cannula market. This dominance is attributed to the fact that the vast majority of complex cardiac surgical procedures, including open-heart surgeries, valve replacements, and critical ECMO interventions, are performed in large, well-equipped hospital settings. Hospitals have the necessary infrastructure, specialized surgical teams, intensive care units, and a broad range of cardiac equipment that necessitates the constant use and replenishment of cardiac cannulas. The high volume of patient admissions for cardiac conditions and the comprehensive nature of care provided ensure hospitals remain the primary and largest consumers of cardiac cannulas globally.
• The fastest-growing segment within the end-user category is Ambulatory Surgical Centers (ASCs). This rapid growth is driven by the global trend towards performing a wider range of less complex or minimally invasive cardiac procedures in outpatient settings, offering cost-effectiveness and patient convenience. While traditional open-heart surgeries remain confined to hospitals, procedures like certain diagnostic cardiac catheterizations and some interventional cardiology procedures may shift to ASCs. This expansion of cardiac services in ASCs, coupled with increasing investments in their infrastructure to handle specific cardiac cases, is accelerating the demand for cannulas suited for these outpatient environments, driving this segment's rapid growth.

Cardiac Cannula Market Regional Insights

The market has been geographically analysed across five regions, Europe, North America, Asia Pacific, Latin America, and the Middle East & Africa.

• North America is currently the largest region in the Cardiac Cannula market. This dominance is primarily due to its highly developed healthcare infrastructure, significant healthcare expenditure, and the high prevalence of cardiovascular diseases within the population. The region benefits from early adoption of advanced medical technologies and surgical techniques, including minimally invasive cardiac procedures and widespread use of ECMO. Furthermore, the presence of major medical device manufacturers and robust reimbursement policies for cardiac interventions contributes to the high volume of procedures and, consequently, the strong demand for cardiac cannulas. National health expenditure data from the US government consistently show high levels of healthcare spending, supporting this market leadership.
• Asia-Pacific is currently the fastest-growing region in the Cardiac Cannula market. This accelerated growth is primarily fueled by rapid improvements in healthcare infrastructure, increasing healthcare expenditure, and a large and aging population, which contributes to a rising incidence of cardiovascular diseases. Countries like China and India are witnessing significant investments in establishing new hospitals and specialized cardiac centers, leading to an expansion of surgical capacities. The Asia-Pacific healthcare market is projected to reach substantial value, driven by demographic shifts and increased investment. This expansion, coupled with growing awareness of cardiovascular health and increasing access to advanced medical treatments, is driving the rapid adoption of cardiac cannulas across the region.

Cardiac Cannula Market Competitive Overview

The competitive landscape of the Cardiac Cannula market is characterized by the presence of a few dominant global players alongside several specialized manufacturers. Competition primarily revolves around product innovation, material advancements for enhanced biocompatibility and reduced complications, and the ability to meet diverse procedural demands, including those for minimally invasive techniques. Companies are focusing on expanding their product portfolios to offer a comprehensive range of cannulas suitable for various applications, such as cardiac surgery, ECMO, and TAVR. Strategic collaborations with healthcare providers and research institutions are common to develop tailored solutions and conduct clinical studies. Adherence to stringent regulatory standards and maintaining robust supply chains are critical competitive differentiators in this highly specialized medical device market.

Leading Market Players in the Cardiac Cannula Market

• Medtronic: Medtronic is a global leader in medical technology, and its cardiovascular portfolio significantly impacts the cardiac cannula market. While not solely focused on cannulas, Medtronic provides a broad array of devices used in cardiac surgical procedures, including those that necessitate advanced cannulation. The company's commitment to innovation in cardiovascular care, encompassing areas such as heart valve therapies, cardiac rhythm management, and surgical solutions, drives the demand for high-quality, reliable cannulas that integrate seamlessly with their sophisticated systems. Medtronic's extensive research and development capabilities, coupled with its global distribution network, ensure its strong influence on market trends and product specifications for cardiac cannulas used in conjunction with its core offerings.
• Edwards Lifesciences: Edwards Lifesciences is a global leader in patient-focused medical innovations for structural heart disease and critical care monitoring, making it a pivotal player in the cardiac cannula market. The company specializes in advanced surgical heart valve therapies and transcatheter heart valve replacement, particularly Transcatheter Aortic Valve Replacement (TAVR), which heavily relies on specialized cannulation techniques. Edwards Lifesciences develops and provides a range of cannulas and associated delivery systems designed for precision, safety, and optimal outcomes in complex cardiac interventions. Their continuous innovation in minimally invasive approaches and their deep expertise in cardiac anatomy and physiology position them as a key driver of advancements in cannula design and application.
• LivaNova: LivaNova is a prominent medical technology company specializing in cardiovascular and neuromodulation solutions. In the context of the cardiac cannula market, LivaNova is a significant provider of cardiopulmonary bypass technologies, including heart-lung machines and associated disposables, of which cardiac cannulas are a critical component. The company offers a comprehensive range of products designed to act as the heart and lungs during open-heart surgical procedures. LivaNova's long-standing expertise in perfusion management and extracorporeal circulation drives its focus on developing cannulas that ensure efficient blood flow, minimize trauma, and enhance patient safety during complex cardiac surgeries, reinforcing its position as a key supplier in this specialized segment.

Top Strategies Followed by Players

• Product Innovation and Technology Advancement: Leading players in the Cardiac Cannula market are heavily investing in product innovation and technology advancement as a core strategy. This involves developing cannulas with enhanced features such as improved biocompatibility to reduce thrombotic complications, optimized tip designs for less invasive access, and integration of smart technologies for real-time procedural guidance. For instance, advancements in 3D printing are influencing medical device design, allowing for more customized and anatomically precise cannulas. This focus on innovation aims to address unmet clinical needs, improve patient safety and outcomes, and differentiate products in a competitive market by offering superior performance and procedural efficiency.
• Strategic Acquisitions and Partnerships: A key strategy employed by market leaders is engaging in strategic acquisitions and partnerships to expand their product portfolios, technological capabilities, and market reach. Companies may acquire smaller, specialized firms with innovative cannula technologies or unique material expertise to strengthen their offerings. Partnerships with academic institutions, research centers, or even healthcare providers can facilitate collaborative research and development, clinical trials, and market penetration. The medical device M&A landscape often shows a strong emphasis on acquiring innovative technologies. These strategic alliances allow companies to leverage complementary strengths, accelerate product development cycles, and gain a competitive edge by offering more comprehensive solutions to the evolving demands of cardiac care.
• Global Market Expansion and Localization: Major players in the Cardiac Cannula market are pursuing a strategy of global market expansion, particularly focusing on emerging economies, while also emphasizing localization to cater to specific regional needs. This involves establishing strong distribution networks, adapting product designs to local clinical practices and regulations, and potentially setting up local manufacturing facilities. For instance, the Asia-Pacific healthcare market is set to experience significant growth, creating opportunities for medical device manufacturers. By expanding their footprint in high-growth regions and understanding the unique healthcare systems and patient demographics, companies can tap into underserved markets, increase their revenue streams, and diversify their revenue base, thereby solidifying their global market presence.

List of Companies Profiled in the Report are:

• Medtronic
• Edwards Lifesciences
• LivaNova
• Andocor
• BD
• Getinge
• Terumo
• Strong Medical
• Boston Scientific Corporation
• Teleflex Incorporated

Global Cardiac Cannula Market Report: Scope

List of Segments Covered

This section of the Cardiac Cannula market report provides detailed data on the segments at country and regional level, thereby assisting the strategist in identifying the target demographics for the respective product or services with the upcoming opportunities.

By Product Type

• Venous Cannulas
• Arterial Cannulas
• Specialized Cannulas
• Multi-purpose Cannulas

By Design Type

• Single-lumen Cannulas
• Multi-lumen Cannulas
• Guide Cannulas
• Bio-compatible Cannulas

By Application

• Cardiac Surgery
• Cardiac Assist Devices
• Extracorporeal Membrane Oxygenation (ECMO)
• Transcatheter Aortic Valve Replacement (TAVR)

By Material

• Silicone
• Polyurethane
• Polyvinyl Chloride (PVC)
• Metal-coated Cannulas

By End User

• Hospitals
• Ambulatory Surgical Centers
• Cardiac Care Units
• Specialized Cardiac Clinics